Cargando…

Breakthrough of COVID-19 using radiotherapy treatment modalities()

Detalles Bibliográficos
Autores principales:	Venkatraman, P., Sahay, J. Joshua, Maidili, T., Rajan, Rajisha, Pooja, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169895/ https://www.ncbi.nlm.nih.gov/pubmed/32342867 http://dx.doi.org/10.1016/j.radonc.2020.04.024

Ejemplares similares

Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
por: Skwarek, Aleksandra, et al.
Publicado: (2021)

Fabrication and Dosimetric Characteristics of Silicon Elastomer-Based Bolus Using External Beam Radiotherapy
por: Boopathi, M, et al.
Publicado: (2023)

Endoscopic management is the preferred “treatment” modality for grade III vesicoureteric reflux with breakthrough infections in a young girl
por: Nerli, R. B.
Publicado: (2008)

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
por: Hsu, Shih-Ming, et al.
Publicado: (2017)

COVID-19 vaccination and breakthrough infections in patients with cancer
por: Schmidt, A.L., et al.
Publicado: (2022)

Endoscopic management is the preferred treatment modality for a Grade III vesicoureteric reflux with breakthrough infections in a young girl
por: Joshi, S. S.
Publicado: (2008)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
por: Stevens, Christina W., et al.
Publicado: (2023)

Clinical characterization of COVID-19 breakthrough infections, Philippines
por: Velasco, John Mark, et al.
Publicado: (2022)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

The “identikit” of subject with obesity and COVID-19 vaccine breakthrough
por: Muscogiuri, Giovanna, et al.
Publicado: (2022)

Breakthrough COVID-19 infections – Analyzing our experience
por: Hussain, Aneela, et al.
Publicado: (2023)

Insulin‐like growth factor binding protein‐4: The quest for the breakthrough biomarker in pulmonary arterial hypertension
por: Estrada, Rodolfo A., et al.
Publicado: (2023)

Alzheimer’s Disease Treatment: The Search for a Breakthrough
por: Reiss, Allison B., et al.
Publicado: (2023)

Breakthrough medicines during the COVID-19 pandemic era
por: Ghali, Eswara Naga Hanuma Kumar, et al.
Publicado: (2022)

Metabolic disorders, COVID-19 and vaccine-breakthrough infections
por: Stefan, Norbert
Publicado: (2021)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Why do breakthrough COVID-19 infections occur in the vaccinated?
por: Maclean, Patrick, et al.
Publicado: (2021)

Vaccine Breakthrough Severe COVID-19 in a Lung Recipient
por: Beyoglu, Muhammet Ali, et al.
Publicado: (2022)

Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities
por: Smits, Peter D., et al.
Publicado: (2023)

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
por: Zhang, Xiaojing, et al.
Publicado: (2022)

Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic
por: Alcendor, Donald J., et al.
Publicado: (2022)

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
por: Bergwerk, Moriah, et al.
Publicado: (2021)

Breakthrough treatments for accelerated wound healing
por: Freedman, Benjamin R., et al.
Publicado: (2023)

Breakthrough!
por: KURNIT, Paul
Publicado: (2010)

Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection
por: Ray, Somdattaa, et al.
Publicado: (2022)

Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience
por: Choi, Seo Hee, et al.
Publicado: (2015)

A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance
por: Ahn, Byeong Yun, et al.
Publicado: (2020)

VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021)

Archetype of Olfactory and Gustatory Dysfunction in Breakthrough COVID-19 Illness
por: Sagar, Prem, et al.
Publicado: (2021)

Predictors of death in COVID-19 vaccine breakthrough infections in Brazil
por: Estofolete, Cassia Fernanda, et al.
Publicado: (2022)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
por: Yekutiel, Naama, et al.
Publicado: (2023)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Immune Responses and Breakthrough Infections After COVID-19 Vaccination
por: Kwon, Ki Tae
Publicado: (2023)

Radiotherapy plus EGFR inhibitors: synergistic modalities
por: Bossi, Paolo, et al.
Publicado: (2017)

RECENT ADVANCES IN RADIOTHERAPY MODALITIES FOR PROSTATE CANCER
por: Murgić, Jure, et al.
Publicado: (2022)

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)

EPH75 COVID-19 Vaccine Breakthrough Infections in the United States, By Race
por: Liu, M, et al.
Publicado: (2022)

COVID-19 breakthrough infections in rheumatic diseases patients after vaccination
por: Alshukairi, Abeer N., et al.
Publicado: (2022)

Academic Research and Institutional Breakthrough: Theoretical Analysis Under COVID-19
por: Bu, Xuelin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jdnteksljorlnp9vv72v4d8equ